PPARα agonists (such as Fenofibrate) can reduce the expression of TXNIP, NLRP3, and caspase-1 in endothelial precursor cells (EPC) of DM mice and accelerate wound healing of DM mice (Deng et al., 2017). Here, NLRP3 is linked to diabetes mellitus.